Insight Molecular Diagnostics Inc. (IMDX) Operating margin 2020–2025
Insight Molecular Diagnostics Inc. (IMDX) operating margin by fiscal year — reported operating income divided by reported revenue.
-1260.8%FY2025 · since FY2020: -2443.3% → -1260.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1260.8% | +1984.4 pp |
| FY2024 | -3245.1% | -1572.7 pp |
| FY2023 | -1672.4% | +206.2 pp |
| FY2022 | -1878.6% | +565.7 pp |
| FY2021 | -2444.3% | -0.9 pp |
| FY2020 | -2443.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice